Prospective Study in a Single Center to Evaluate the Impact, Safety, Tolerability and Immunogenicity of the Coronavac Vaccine in Kidney Transplant Recipients
Latest Information Update: 06 Mar 2024
At a glance
- Drugs SARS-COV-2 vaccine-inactivated-Sinovac-Biotech (Primary)
- Indications COVID 2019 infections
- Focus Therapeutic Use
- Acronyms TXCoronavac
- 05 Aug 2022 Results published in the Transplantation
- 07 Dec 2021 Results published in the Transplantation
- 23 Aug 2021 Planned End Date changed from 1 Mar 2022 to 1 Mar 2023.